Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

C16038: An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (Phase IV)

  • Details

ClinicalTrials.gov ID: NCT03173092
Diagnosis Type: NA
USOR Number: 17081

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

SGN35-027: Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

  • Details

ClinicalTrials.gov ID: NCT03646123
Diagnosis Type: NA
USOR Number: 18013

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer

  • Details

ClinicalTrials.gov ID: NCT03940196
Diagnosis Type: NA
USOR Number: 18269

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Uterine Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Kidney Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Sarcoma

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Penile Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Vaginal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Liver Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
43.22 mi. away
P: (303) 385-2000

More Details View Practice Page

Pages